Mon. 18 Mar 2024, 4:09pm ET
Benzinga
Earnings, News
Tenaya Therapeutics (NASDAQ:TNYA) reported quarterly losses of $(0.40) per share which beat the analyst consensus estimate of $(0.44) by 9.09 percent. This is a 34.43 percent increase over losses of $(0.61) per share from the same period last year.